Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 6/20 | 0.58 |
| ▸ | CTSS | P25774 | 3/20 | 0.58 |
| ▸ | CTSK | P43235 | 3/20 | 0.58 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.56 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.54 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.52 |
| ▸ | CTSB | P07858 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | CTSG | P08311 | 1/20 | 0.50 |
| ▸ | TACR1 | P25103 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13673427 | 0.94 | CTSL (0.60) | CTSLCTSSCTSKPSMB5GPR139 | |
| SCHEMBL13673425 | 0.90 | GAA (0.65) | CTSLCTSSCTSKGAARAB9A | |
| SCHEMBL16667786 | 0.84 | GAA (0.62) | CTSLCTSSCTSKPSMB5GAA | |
| SCHEMBL14479041 | 0.84 | CTSL (0.52) | CTSLCTSSCTSKPSMB5GPR139 | |
| SCHEMBL4372161 | 0.83 | CTSL (0.61) | CTSLCTSSCTSKPSMB5CTRB1 | |
| SCHEMBL13669573 | 0.82 | GAA (0.69) | CTSLCTSSCTSKPSMB5GPR139 | |
| SCHEMBL4369272 | 0.82 | GAA (0.69) | CTSLCTSSCTSKPSMB5GPR139 | |
| Aurantiamide Acetate SCHEMBL30532189 | 0.81 | CTSL (0.71) | CTSLCTSSCTSKPSMB5GPR139 | |
| Aurantiamide Acetate SCHEMBL31084254 | 0.81 | CTSL (0.71) | CTSLCTSSCTSKPSMB5GPR139 | |
| Aurantiamide Acetate SCHEMBL30004267 | 0.81 | CTSL (0.71) | CTSLCTSSCTSKPSMB5GPR139 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090247470-A1 | PHENYLALANINE DIPEPTIDE DERIVATIVES, COMPOSITIONS AND USE THEREOF | The Key Lab. Of Chemistry for Natural Products of Guizhou Province and Chinese Acad. of Sciences (CN) | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247470-A1 | PHENYLALANINE DIPEPTIDE DERIVATIVES, COMPOSITIONS AND USE THEREOF | DNPEP, PEPD, VIP | CTSL 591/4885CTSS 3153/4885CTSK 2637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.